Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Substance-Related Disorders × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Substance-Related Disorders 1 Prostatic Neoplasms 1 Postoperative Nausea and Vomiting 1 Opioid-Related Disorders 1 Nausea 1 Lymphoma, Follicular 1 Colorectal Neoplasms 1

Interventions

Therapeutics 1 Dosage Forms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04345718 2025-12-09

EXHITENTRE

Hennepin Healthcare Research Institute

Phase 2/3 Completed

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡